TUG1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.338200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.956400E-01
Normal-vs-Stage2
6.294200E-02
Normal-vs-Stage3
1.337640E-01
Normal-vs-Stage4
4.441600E-01
Stage1-vs-Stage2
3.139800E-01
Stage1-vs-Stage3
5.080400E-02
Stage1-vs-Stage4
7.584400E-01
Stage2-vs-Stage3
1.610000E-01
Stage2-vs-Stage4
6.104800E-01
Stage3-vs-Stage4
1.992230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.968200E-02
Normal-vs-AfricanAmerican
3.088000E-01
Normal-vs-Asian
2.504600E-01
Caucasian-vs-AfricanAmerican
7.904000E-01
Caucasian-vs-Asian
6.865600E-01
AfricanAmerican-vs-Asian
9.783600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.100000E-02
Normal-vs-Female
9.247900E-02
Male-vs-Female
1.878600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.240600E-01
Normal-vs-Age(41-60Yrs)
5.159000E-01
Normal-vs-Age(61-80Yrs)
4.821600E-02
Normal-vs-Age(81-100Yrs)
5.264300E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.753200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.808000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.595600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.204700E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.096080E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.064800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.013840E-01
Normal-vs-Daily Drinker
4.256100E-02
Normal-vs-Weekly Drinker
2.121400E-01
Normal-vs-Occasional Drinker
8.700300E-02
Normal-vs-Social Drinker
5.163000E-01
Non Drinker-vs-Daily Drinker
3.342400E-01
Non Drinker-vs-Weekly Drinker
6.299200E-01
Non Drinker-vs-Occasional Drinker
7.610800E-01
Non Drinker-vs-Social Drinker
1.513650E-01
Daily Drinker-vs-Weekly Drinker
2.064200E-01
Daily Drinker-vs-Occasional Drinker
2.070800E-01
Daily Drinker-vs-Social Drinker
3.060100E-02
Weekly Drinker-vs-Occasional Drinker
8.129800E-01
Weekly Drinker-vs-Social Drinker
5.324800E-01
Occasional Drinker-vs-Social Drinker
2.738800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.925000E-01
Normal-vs-Grade 2
7.005400E-01
Normal-vs-Grade 3
6.966000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.090620E-01
Grade 1-vs-Grade 3
1.558160E-01
Grade 1-vs-Grade 4
7.925000E-01
Grade 2-vs-Grade 3
9.209600E-01
Grade 2-vs-Grade 4
7.005400E-01
Grade 3-vs-Grade 4
6.966000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.288230E-02
Normal-vs-NonDiabetic
5.669600E-02
Diabetic-vs-NonDiabetic
1.160440E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.228800E-01
Normal-vs-NoPancreatitis
3.189800E-02
Pancreatitis-vs-NoPancreatitis
2.030800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.956400E-02
Normal-vs-N1
6.080400E-02
N0-vs-N1
8.044800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.112800E-01
Normal-vs-TP53-NonMutant
1.562360E-01
TP53-Mutant-vs-TP53-NonMutant
7.322200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
